denufosol tetrasodium Inhalation Solution

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Cystic Fibrosis

Phase 2

A Safety and Tolerability Study of Denufosol in 2-4 Year Olds

CompletedNCT01181622

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2010-08-31End: 2010-10-31Updated: 2015-01-13

Phase 3

Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)

TerminatedNCT00846781

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2009-02-28End: 2011-02-28Updated: 2015-11-06